Yasser A Radwan1,2, Reto D Kurmann3,4, Avneek S Sandhu1, Edward A El-Am3,5, Cynthia S Crowson1,6, Eric L Matteson1,6, Thomas G Osborn1, Kenneth J Warrington1, Rekha Mankad3, Ashima Makol1. 1. Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA. 2. Department of Internal Medicine, Michigan State University, East Lansing, MI, USA. 3. Division of Cardiovascular Disease, Mayo Clinic College of Medicine and Science, Rochester, MN, USA. 4. Department of Cardiology, Luzerner Kantonsspital, Lucerne, Switzerland. 5. Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. 6. Department of Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Abstract
Objectives: To study the incidence, risk factors and outcomes of conduction and rhythm disorders in a population-based cohort of patients with systemic sclerosis (SSc) vs. non-SSc comparators. Methods: An incident cohort of patients with SSc (1980-2016) from Olmsted County, MN was compared to age- and sex-matched non-SSc subjects (1:2). Electrocardiograms (ECGs), Holter ECGs, and need for cardiac interventions were reviewed to determine the occurrence of any conduction or rhythm abnormalities. Results: 78 incident SSc cases and 156 comparators were identified (mean age 56 y, 91% female). The prevalence of any conduction disorder prior to SSc diagnosis compared to non-SSc subjects was 15% vs. 7% (p=0.06), and any rhythm disorder was 18% vs. 13% (p=0.33). During a median follow-up of 10.5 years in patients with SSc and 13.0 years in non-SSc comparators, conduction disorders developed in 25 patients with SSc with cumulative incidence of 20.5% (95% CI: 12.4-34.1%) vs. 28 non-SSc patients with cumulative incidence of 10.4% (95% CI: 6.2-17.4%) (HR: 2.57; 95% CI: 1.48-4.45), while rhythm disorders developed in 27 patients with SSc with cumulative incidence of 27.3% (95% CI: 17.9-41.6%) vs. 43 non-SSc patients with cumulative incidence of 18.0% (95% CI: 12.3-26.4%) (HR: 1.62; 95% CI: 1.00-2.64). Age, pulmonary hypertension and smoking were identified as risk factors. Conclusion: Patients with SSc have an increased risk of conduction and rhythm disorders both at disease onset and over time, compared to non-SSc patients. These findings warrant increased vigilance and screening for ECG abnormalities in SSc patients with pulmonary hypertension.
Objectives: To study the incidence, risk factors and outcomes of conduction and rhythm disorders in a population-based cohort of patients with systemic sclerosis (SSc) vs. non-SSc comparators. Methods: An incident cohort of patients with SSc (1980-2016) from Olmsted County, MN was compared to age- and sex-matched non-SSc subjects (1:2). Electrocardiograms (ECGs), Holter ECGs, and need for cardiac interventions were reviewed to determine the occurrence of any conduction or rhythm abnormalities. Results: 78 incident SSc cases and 156 comparators were identified (mean age 56 y, 91% female). The prevalence of any conduction disorder prior to SSc diagnosis compared to non-SSc subjects was 15% vs. 7% (p=0.06), and any rhythm disorder was 18% vs. 13% (p=0.33). During a median follow-up of 10.5 years in patients with SSc and 13.0 years in non-SSc comparators, conduction disorders developed in 25 patients with SSc with cumulative incidence of 20.5% (95% CI: 12.4-34.1%) vs. 28 non-SSc patients with cumulative incidence of 10.4% (95% CI: 6.2-17.4%) (HR: 2.57; 95% CI: 1.48-4.45), while rhythm disorders developed in 27 patients with SSc with cumulative incidence of 27.3% (95% CI: 17.9-41.6%) vs. 43 non-SSc patients with cumulative incidence of 18.0% (95% CI: 12.3-26.4%) (HR: 1.62; 95% CI: 1.00-2.64). Age, pulmonary hypertension and smoking were identified as risk factors. Conclusion: Patients with SSc have an increased risk of conduction and rhythm disorders both at disease onset and over time, compared to non-SSc patients. These findings warrant increased vigilance and screening for ECG abnormalities in SSc patients with pulmonary hypertension.
Authors: P M Seferović; A D Ristić; R Maksimović; D S Simeunović; G G Ristić; G Radovanović; D Seferović; B Maisch; M Matucci-Cerinic Journal: Rheumatology (Oxford) Date: 2006-10 Impact factor: 7.580
Authors: Giacomo De Luca; Corrado Campochiaro; Maria De Santis; Silvia Sartorelli; Giovanni Peretto; Simone Sala; Giovanni Canestrari; Enrico De Lorenzis; Cristina Basso; Stefania Rizzo; Gaetano Thiene; Anna Palmisano; Antonio Esposito; Carlo Selmi; Elisa Gremese; Paolo Della Bella; Lorenzo Dagna; Silvia Laura Bosello Journal: Rheumatology (Oxford) Date: 2020-09-01 Impact factor: 7.580
Authors: J B Kostis; J R Seibold; D Turkevich; A T Masi; R G Grau; T A Medsger; V D Steen; P J Clements; L Szydlo; W A D'Angelo Journal: Am J Med Date: 1988-06 Impact factor: 4.965
Authors: G De Luca; S Bosello; A M Leone; F Gabrielli; G Pelargonio; F Inzani; F Crea; G Ferraccioli Journal: Scand J Rheumatol Date: 2016-04-21 Impact factor: 3.641
Authors: Shervin Assassi; Deborah Del Junco; Kari Sutter; Terry A McNearney; John D Reveille; Andrew Karnavas; Pravitt Gourh; Rosa M Estrada-Y-Martin; Michael Fischbach; Frank C Arnett; Maureen D Mayes Journal: Arthritis Rheum Date: 2009-10-15
Authors: Eric Hachulla; Patrick Carpentier; Virginie Gressin; Elisabeth Diot; Yannick Allanore; Jean Sibilia; David Launay; Luc Mouthon; Patrick Jego; Jean Cabane; Pascal de Groote; Amélie Chabrol; Isabelle Lazareth; Loïc Guillevin; Pierre Clerson; Marc Humbert Journal: Rheumatology (Oxford) Date: 2009-01-27 Impact factor: 7.580